Author: Konstantinopoulos Panagiotis A Papavassiliou Athanasios G
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.14, Iss.12, 2005-12, pp. : 1471-1474
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Copper and iron complexes with antitumour activity
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. :
Antitumour Effects of Bisphosphonates: First Evidence and Possible Mechanisms
By Diel I.J.
Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. :
Thalidomide potentiated the antitumour activity of cyclophosphamide in mice
Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. :
uPA-anthrax toxin: promising antitumour activity
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :